aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea. Ceftobiprole was turned down by the FDA in 2009 for ABSSSI, when the drug was partnered ...

The MRSA superbug has evolved into 'fitter' strains which could prove even more resistant to treatment, a leading scientist warned on Tuesday. Professor Hajo Grundmann, a world expert in ...

This segment is sponsored content and not a product of WSAZ news. If you are interested in a paid promotion through WSAZ advertising, use the email address [email protected].